For: | Miceli V. Use of priming strategies to advance the clinical application of mesenchymal stromal/stem cell-based therapy. World J Stem Cells 2024; 16(1): 7-18 [PMID: 38292438 DOI: 10.4252/wjsc.v16.i1.7] |
---|---|
URL: | https://www.wjgnet.com/1948-0210/full/v16/i1/7.htm |
Number | Citing Articles |
1 |
Pan Gao, Yoshiko Inada, Maria José López-Iniesta, Chengzhu Zhao, Megumi Goto, Akitsu Hotta, Hidetoshi Sakurai, Makoto Ikeya. Combined rapamycin and mesenchymal stem/stromal cells derived from induced pluripotent stem cells-mediated delivery of ACVR2B-Fc fusion protein reduces heterotopic ossification in a mouse model of fibrodysplasia ossificans progressiva. JBMR Plus 2025; 9(6) doi: 10.1093/jbmrpl/ziaf068
|
2 |
Jee-Hoon Nam, Jeong Hyun Moon, Byeol Choi, Geun-Hyung Kang, Yunok Park, Se-Yeon Park, Tae-Hyun Ko, Donghee Shin, YoungSu Jung, Si-Na Kim, Yun-Kyoung Cho, Myung-Shin Jeon. IFN-α and vitamin B6-induced galectin-9 promotes the immunomodulatory function of human clonal mesenchymal stem cells. Stem Cell Research & Therapy 2025; 16(1) doi: 10.1186/s13287-025-04394-3
|
3 |
Alaa Zeinhom, Sahar A. Fadallah, Marwa Mahmoud. Human mesenchymal stem/stromal cell based-therapy in diabetes mellitus: experimental and clinical perspectives. Stem Cell Research & Therapy 2024; 15(1) doi: 10.1186/s13287-024-03974-z
|